Castle Biosciences CSTL Retained Earnings
Retained Earnings at other companies
Other financials
Where this comes from
Reported directly by Castle Biosciences in its filing.
Tagged under the XBRL concept us-gaap:RetainedEarningsAccumulatedDeficit.
The official record: Castle Biosciences’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Castle Biosciences's retained earnings.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Castle Biosciences's retained earnings?
- Castle Biosciences (CSTL) reported retained earnings of -$238.81M in Q1 2026.
- How has Castle Biosciences's retained earnings changed year-over-year?
- Castle Biosciences's retained earnings decreased by 5.7% year-over-year, from -$225.97M to -$238.81M.
- What is the long-term trend for Castle Biosciences's retained earnings?
- Over 5 years (2020 to 2025), Castle Biosciences's retained earnings has grown at a 29.1% compound annual growth rate (CAGR), from -$62.5M to -$224.28M.
- What does retained earnings mean?
- Cumulative net income earned since inception minus all dividends paid — the total profits reinvested in the business over its lifetime.